Table 1.
Healthy individuals | Chronic HCV with elevated ALT | HCV carriers with PNALT | |
Percentage of PBL | |||
CD3+CD4+ | 29.38 ± 8.11 | 33.15 ± 9.08 | 34.46 ± 6.49 |
CD3+CD4+CD25+ | 4.27 ± 1.62 | 4.05 ± 1.57 | 5.24 ± 1.43 |
CD3+CD4+CD25bright+ | 0.52 ± 0.26 | 0.38 ± 0.26 | 0.40 ± 0.13 |
CD3+CD56+ | 2.99 ± 1.73 | 5.07 ± 4.15 | 3.48 ± 2.72 |
CD3-CD56+ | 17.34 ± 7.42 | 16.42 ± 5.26 | 17.04 ± 7.71 |
CD3-CD56dim+ | 16.04 ± 7.36 | 14.58 ± 5.72 | 15.92 ± 7.14 |
CD3-CD56bright+ | 1.15 ± 0.64 | 1.75 ± 1.54 | 1.27 ± 1.01 |
CD3+CD8+ | 28.59 ± 4.55 | 25.27 ± 8.77 | 24.66 ± 6.14 |
Statistical comparisons were made by using the ANOVA tests. The results were expressed as the mean value ± SD. HCV: Hepatitis C virus; ALT: Alanine aminotransferase; PNALT: Persistently normal ALT; NK: Natural killer cell.